Player FM - Internet Radio Done Right
23 subscribers
Checked 2y ago
Adicionado há nove anos atrás
Conteúdo fornecido por Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International). Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International) ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Player FM - Aplicativo de podcast
Fique off-line com o app Player FM !
Fique off-line com o app Player FM !
Biologic Therapy In Rheumatoid Arthritis
Marcar/Desmarcar tudo como reproduzido ...
Manage series 1199499
Conteúdo fornecido por Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International). Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International) ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Biologic Therapy in Rheumatoid Arthritis: Pioneers in Research, is a monthly series of podcasts featuring interviews with today's giants in rheumatology sponsored by Schering-Plough Corporation. In this series brought to you by Rheumatology News International, you will hear some of the greatest scientists in rheumatology describe the exploration of what was then uncharted medical territory. Their words will bring alive the journey of discovery that placed them in the annals of history's great medical investigators.
…
continue reading
6 episódios
Marcar/Desmarcar tudo como reproduzido ...
Manage series 1199499
Conteúdo fornecido por Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International). Todo o conteúdo do podcast, incluindo episódios, gráficos e descrições de podcast, é carregado e fornecido diretamente por Rheumatology News International and Rhnews@elsevier.com (Rheumatology News International) ou por seu parceiro de plataforma de podcast. Se você acredita que alguém está usando seu trabalho protegido por direitos autorais sem sua permissão, siga o processo descrito aqui https://pt.player.fm/legal.
Biologic Therapy in Rheumatoid Arthritis: Pioneers in Research, is a monthly series of podcasts featuring interviews with today's giants in rheumatology sponsored by Schering-Plough Corporation. In this series brought to you by Rheumatology News International, you will hear some of the greatest scientists in rheumatology describe the exploration of what was then uncharted medical territory. Their words will bring alive the journey of discovery that placed them in the annals of history's great medical investigators.
…
continue reading
6 episódios
Todos os episódios
×B
Biologic Therapy In Rheumatoid Arthritis

1 Episode 6: Individualizing Therapy: Today’s Options, Tomorrow’s Opportunities 19:02
19:02
Mais Tarde
Mais Tarde
Listas
Like
Curtido19:02
This sixth podcast program, Individualizing Therapy: Today’s Options, Tomorrow’s Opportunities, features an interview with Professor McInnes. He discusses the current state of knowledge in rheumatoid arthritis and directions for discovery in coming years.
B
Biologic Therapy In Rheumatoid Arthritis

1 Episode 5: Progress and Prognosis: Evaluating Patients' Responses to Biologic Therapy 16:18
16:18
Mais Tarde
Mais Tarde
Listas
Like
Curtido16:18
This fifth podcast titled Progress and Prognosis: Evaluating Patients’ Responses to Biologic Therapy features a telephone interview with Professor Schett. He discusses differences among the anti-TNF agents in the treatment of rheumatoid arthritis.
B
Biologic Therapy In Rheumatoid Arthritis

1 Episode 4: Individualizing Treatment in Rheumatoid Arthritis: The Crucial Impact of Patient Heterogeneity 14:21
14:21
Mais Tarde
Mais Tarde
Listas
Like
Curtido14:21
Professor VonVollenhoven discusses factors which distinguish individual responses by patients with rheumatoid arthritis to various anti-TNF agents. He describes observations of radiologic and clinical progression of illness in subgroups of patients and provides an overview of considerations in choosing one pharmacologic agent over another. Professor VonVollenhoven also discusses recent research on the role of biologic markers for RA.…
B
Biologic Therapy In Rheumatoid Arthritis

1 Episode 3: Anti-TNF Treatment: Focus on early Rheumatoid Arthritis. Featuring an interview with Professor Paul Emery 14:21
14:21
Mais Tarde
Mais Tarde
Listas
Like
Curtido14:21
Contemporary research shows that the early diagnosis and treatment of RA can offer patients the possibility of achieving remission. The goal for any patient with early RA should be to achieve remission. If a patient does not already have joint damage, the goal should be a normal acute-phase response and no swollen joints as soon as possible.…
B
Biologic Therapy In Rheumatoid Arthritis

1 Episode 2: Establishing the Evidence: Clinical Trials with TNF Inhibitors 14:53
14:53
Mais Tarde
Mais Tarde
Listas
Like
Curtido14:53
Professor Smolen discusses the evidence supporting the ability of TNF-alpha agents to result in substantial and sustained improvement in symptoms of psoriatic arthritis. Agents including infliximab and etanercept result in not only clinical improvement but also slow the radiographic progression of joint disease and damage. Further, the combination therapy of a TNF-alpha agent and methotrexate results in highly significant improvement in arthritic symptoms and signs.…
B
Biologic Therapy In Rheumatoid Arthritis

1 Episode 1: TNF-Alpha: Concept to Proof of Concept 14:53
14:53
Mais Tarde
Mais Tarde
Listas
Like
Curtido14:53
Professor Sir Ravinder Maini's groundbreaking work on the characterization of TNF-alpha began in the mid-1980's with his collaboration with Professor Mark Feldman. In his study of intercellular messenger molecules, Professor Sir Maini utilized two new technologies -- protein sequencing and cDNA protein coding -- to investigate half a dozen cytokines that appeared to mediate the pathogenesis of connective tissue diseases. One of them, TNF-alpha, proved to play a pivotal role in the cascading interaction of cytokines. When antibody against TNF-alpha was produced, a new field of biologic therapy in the management of rheumatic diseases was born. In this interview, Professor Sir Maini describes the scientific discovery that earned him the title "Father of Translational Research." Listen to him describe this historic exploration in his own words. The podcast also features: Inflammation is Hallmark of Coronary Disease in RA…
Bem vindo ao Player FM!
O Player FM procura na web por podcasts de alta qualidade para você curtir agora mesmo. É o melhor app de podcast e funciona no Android, iPhone e web. Inscreva-se para sincronizar as assinaturas entre os dispositivos.